CY2011004I2 - Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων - Google Patents

Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Info

Publication number
CY2011004I2
CY2011004I2 CY2011004C CY2011004C CY2011004I2 CY 2011004 I2 CY2011004 I2 CY 2011004I2 CY 2011004 C CY2011004 C CY 2011004C CY 2011004 C CY2011004 C CY 2011004C CY 2011004 I2 CY2011004 I2 CY 2011004I2
Authority
CY
Cyprus
Prior art keywords
chimeral
circular dna
dna clones
pig circular
infectious
Prior art date
Application number
CY2011004C
Other languages
English (en)
Other versions
CY2011004I1 (el
Original Assignee
Iowa State University Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iowa State University Research Foundation, Inc. filed Critical Iowa State University Research Foundation, Inc.
Publication of CY2011004I1 publication Critical patent/CY2011004I1/el
Publication of CY2011004I2 publication Critical patent/CY2011004I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CY2011004C 2001-12-12 2011-05-06 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων CY2011004I2 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34077501P 2001-12-12 2001-12-12
US42484002P 2002-11-08 2002-11-08
US10/314,512 US7276353B2 (en) 2001-12-12 2002-12-09 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
PCT/US2002/039646 WO2003049703A2 (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof

Publications (2)

Publication Number Publication Date
CY2011004I1 CY2011004I1 (el) 2014-04-09
CY2011004I2 true CY2011004I2 (el) 2015-10-07

Family

ID=27405726

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20111100127T CY1111167T1 (el) 2001-12-12 2011-02-03 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
CY2011004C CY2011004I2 (el) 2001-12-12 2011-05-06 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
CY181101151T CY1121112T1 (el) 2001-12-12 2018-11-05 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20111100127T CY1111167T1 (el) 2001-12-12 2011-02-03 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY181101151T CY1121112T1 (el) 2001-12-12 2018-11-05 Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων

Country Status (30)

Country Link
US (1) US7276353B2 (el)
EP (5) EP2264050B1 (el)
JP (1) JP4623964B2 (el)
KR (1) KR101014544B1 (el)
CN (2) CN103536911B (el)
AT (1) ATE487490T1 (el)
AU (3) AU2002362147C1 (el)
BE (1) BE2011C008I2 (el)
BR (1) BRPI0214919B1 (el)
CA (2) CA2784260C (el)
CO (1) CO5590938A2 (el)
CY (3) CY1111167T1 (el)
DE (2) DE122011100001I1 (el)
DK (3) DK2264050T3 (el)
ES (3) ES2694505T3 (el)
HK (1) HK1151988A1 (el)
HR (3) HRP20040626B9 (el)
HU (5) HU231162B1 (el)
LT (1) LT2264050T (el)
LU (1) LU91814I2 (el)
ME (1) ME00126B (el)
MX (1) MXPA04005364A (el)
NL (1) NL300480I2 (el)
NZ (2) NZ533256A (el)
PL (3) PL214803B1 (el)
PT (3) PT2264050T (el)
RS (1) RS51288B (el)
SI (3) SI1487483T1 (el)
TW (1) TWI314580B (el)
WO (1) WO2003049703A2 (el)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CN1749397B (zh) * 2004-08-18 2010-12-08 金宁一 共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗
ES2733428T3 (es) 2004-12-30 2019-11-29 Boehringer Ingelheim Animal Health Usa Inc Composiciones inmunogénicas frente a PCV2 y métodos para producir composiciones de este tipo
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
CN1328373C (zh) * 2005-04-07 2007-07-25 南京农业大学 猪ⅱ型圆环病毒重组腺病毒
EP1896069B1 (en) * 2005-06-24 2013-03-13 Intervet International BV Inactivated chimeric vaccines and related methods of use
US20080248061A1 (en) * 2005-09-09 2008-10-09 Intervet International B.V. Pcv-2 Vaccine
PL1968630T3 (pl) 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multiwalentne immunogenne kompozycje PCV2
CN104383526B (zh) * 2005-12-29 2018-09-18 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2免疫原性组合物用于减轻猪临床症状的用途
JP4625485B2 (ja) * 2006-09-29 2011-02-02 財団法人大阪産業振興機構 高病原性トリインフルエンザウイルスに対するモノクローナル抗体
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
US20100129397A1 (en) * 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP2094872B2 (en) * 2006-12-15 2020-02-19 Boehringer Ingelheim Animal Health USA Inc. Treatment of anti-PCV2 antibody seropositive pigs with PCV2 antigen
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
KR20100025529A (ko) * 2007-05-30 2010-03-09 와이어쓰 엘엘씨 돼지 바이러스의 유전자를 발현하는 라쿤 폭스바이러스
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
MX2010005014A (es) * 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
EP2225367A1 (en) * 2007-12-21 2010-09-08 Wyeth LLC Methods and compositions for immunizing pigs against porcine circovirus
US20110020394A1 (en) * 2007-12-31 2011-01-27 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
EP2242511A4 (en) * 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
WO2009103037A1 (en) * 2008-02-15 2009-08-20 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
AU2009236669B2 (en) * 2008-04-16 2012-12-06 Virginia Tech Intellectual Properties, Inc. Chimeric porcine circovirus PCV2Gen-1Rep and uses thereof
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
DK2547770T3 (da) 2010-03-16 2020-03-02 Virginia Tech Intellectual Properties Inc Levende svækket kimær porcint circovirusvaccine
TWI442935B (zh) 2010-12-22 2014-07-01 Sbc Virbac Ltd 豬第二型環狀病毒（Ｐｏｒｃｉｎｅ Ｃｉｒｃｏｖｉｒｕｓ Ｔｙｐｅ ２）、含彼之免疫組合物、檢測套組及其應用
JP5831913B2 (ja) 2010-12-28 2015-12-09 Ｊｘ日鉱日石エネルギー株式会社 有機化合物の水素化装置及び水素化方法
HUP1100470A2 (en) * 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
UA113192C2 (xx) 2011-12-06 2016-12-26 Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
KR102217387B1 (ko) * 2013-03-11 2021-02-19 주식회사 중앙백신연구소 재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
EA035265B1 (ru) 2013-10-02 2020-05-21 Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
CN103602759B (zh) * 2013-11-22 2015-09-23 福建省农业科学院畜牧兽医研究所 一种区别鸭圆环病毒和鹅圆环病毒的pcr-rflp方法
CN110354258A (zh) 2013-12-03 2019-10-22 英特维特国际股份有限公司 抗猪圆环病毒2型的疫苗
US20190091320A1 (en) * 2016-03-07 2019-03-28 Virginia Tech Intellectual Properties, Inc. Chimeric porcine circovirus type 2 (pcv2) vaccines
CN106497892A (zh) * 2016-09-07 2017-03-15 扬州大学 带KT3标签的重组病毒rPCV2‑KT3的构建方法
JP7162072B2 (ja) 2018-03-26 2022-10-27 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 免疫原性組成物を製造する方法
CN112898435B (zh) * 2021-01-14 2023-03-31 山西农业大学 一种可溶性融合蛋白DT390-Cap及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769322B1 (fr) 1997-10-03 2002-03-08 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
FR2769321B1 (fr) 1997-10-03 2001-10-26 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
PT2363488E (pt) * 1997-12-11 2015-01-13 Univ Belfast Síndrome multi-sistémica do definhamento pós-desmame de porcos
WO1999045956A1 (en) 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
EP1311698A2 (en) 2000-05-03 2003-05-21 University Of Guelph Porcine adenovirus type 5 vector and vaccine
KR20030036194A (ko) 2000-05-24 2003-05-09 메리알 돼지 생식기 호흡기 증후군 바이러스(ｐｒｒｓｖ) 재조합아비폭스바이러스 백신
WO2001096377A2 (en) 2000-06-15 2001-12-20 Purdue Research Foundation Vaccine for congenital tremors in pigs
DE10044648A1 (de) 2000-09-08 2002-03-21 Aventis Behring Gmbh Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
MY148759A (en) 2001-03-27 2013-05-31 Univ Saskatchewan Methods to culture circovirus
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines

Also Published As

Publication number Publication date
SI2264050T1 (sl) 2018-12-31
CN103536911A (zh) 2014-01-29
EP2264050B1 (en) 2018-08-08
ME00126B (me) 2010-10-10
NZ567688A (en) 2009-09-25
AU2011200843B2 (en) 2012-01-19
LT2264050T (lt) 2018-11-26
CY2011004I1 (el) 2014-04-09
US20030170270A1 (en) 2003-09-11
AU2008202333B2 (en) 2010-11-25
DK1487483T3 (da) 2011-02-21
DE122011100001I1 (de) 2011-09-08
HUS2100036I1 (hu) 2021-09-28
HRP20140003A2 (hr) 2014-11-07
CO5590938A2 (es) 2005-12-30
CN1620310B (zh) 2014-11-26
ATE487490T1 (de) 2010-11-15
PT2263689E (pt) 2015-02-13
CA2469599A1 (en) 2003-06-19
EP2263689B1 (en) 2014-11-12
EP1487483A4 (en) 2006-02-15
DK2263689T3 (en) 2015-02-02
CY1111167T1 (el) 2014-04-09
TW200307042A (en) 2003-12-01
JP2005511075A (ja) 2005-04-28
EP3388515A1 (en) 2018-10-17
WO2003049703A3 (en) 2004-09-30
CN103536911B (zh) 2019-09-13
PL374382A1 (en) 2005-10-17
AU2002362147B2 (en) 2008-03-13
PT1487483E (pt) 2011-02-10
SI1487483T1 (sl) 2011-03-31
EP2263689A2 (en) 2010-12-22
PL214803B1 (pl) 2013-09-30
HRP20140002A2 (hr) 2014-11-07
HU228584B1 (en) 2013-04-29
AU2008202333A1 (en) 2008-06-19
HUP1300097A2 (en) 2007-12-28
TWI314580B (en) 2009-09-11
BE2011C008I2 (el) 2022-02-02
HRP20140003B1 (hr) 2020-10-16
ES2694505T3 (es) 2018-12-21
HRP20040626A2 (en) 2006-03-31
EP2264050A2 (en) 2010-12-22
EP2264050A3 (en) 2011-04-20
RS51288B (sr) 2010-12-31
SI2263689T1 (sl) 2015-03-31
LU91814I2 (fr) 2011-07-04
KR101014544B1 (ko) 2011-02-16
PL395510A1 (pl) 2011-12-19
JP4623964B2 (ja) 2011-02-02
PL215058B1 (pl) 2013-10-31
NZ533256A (en) 2008-06-30
HRP20040626B9 (hr) 2016-09-23
CA2784260A1 (en) 2003-06-19
EP2263690A2 (en) 2010-12-22
AU2011200843A1 (en) 2011-03-17
WO2003049703A8 (en) 2005-12-01
PT2264050T (pt) 2018-11-21
BR0214919A (pt) 2006-05-30
US7276353B2 (en) 2007-10-02
DE60238278D1 (de) 2010-12-23
CA2784260C (en) 2016-05-17
HRP20140002B1 (hr) 2020-10-16
HK1151988A1 (en) 2012-02-17
BRPI0214919B1 (pt) 2015-09-15
RS51704A (en) 2006-10-27
EP1487483A2 (en) 2004-12-22
EP2263689A3 (en) 2011-04-20
AU2002362147A1 (en) 2003-06-23
MEP17708A (en) 2010-06-10
WO2003049703A2 (en) 2003-06-19
ES2355814T3 (es) 2011-03-31
HUP0501000A2 (en) 2007-12-28
CN1620310A (zh) 2005-05-25
CY1121112T1 (el) 2019-12-11
HRP20040626B1 (hr) 2016-08-26
CA2469599C (en) 2012-10-23
HU231018B1 (hu) 2019-11-28
DK2264050T3 (en) 2018-12-03
ES2529726T3 (es) 2015-02-25
KR20040086243A (ko) 2004-10-08
PL395509A1 (pl) 2011-12-19
EP2263690A3 (en) 2011-06-08
EP1487483B1 (en) 2010-11-10
HU230576B1 (hu) 2017-01-30
NL300480I2 (el) 2016-11-01
HU231162B1 (hu) 2021-05-28
MXPA04005364A (es) 2004-09-27
AU2002362147C1 (en) 2012-05-17

Similar Documents

Publication Publication Date Title
CY2011004I1 (el) Χιμαιρικοι λοιμωδεις κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων
DE60238478D1 (de) Eren
DE60212600D1 (de) Audiocodierung und decodierung
DE60229216D1 (de) Mram architektur und system
DE60206625D1 (de) Haarkonditionierungsmittel
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DE60223344D1 (de) Silicoaluminophosphat-molekularsieb
DE60203563D1 (de) Zentripetale Abblasvorrichtung
DE60215407D1 (de) Wagen und Träger
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
DE60204686D1 (de) 3-arylsubstituierte zyklopentadienyl-metal-komplexe und polymerisationsverfahren
DE50211354D1 (de) Transportwagen
NO20030239D0 (no) Modifisert virus
NO20022092L (no) Orienterings- og lokaliseringssystem
DE60223044D1 (de) Granulatförmiges herbizid
DE60227607D1 (de) Spielsystem und Spielprogramm
NO20033919L (no) Ny anvendelse
DE60201861D1 (de) Stahlherstellungsverfahren
FI20010432A0 (fi) Puhallin
DE60207900D1 (de) "Suspend"-Paketübertrager
DE1251056T1 (de) Transportkarren
FR2821760B1 (fr) Le cochonnet aimante
NO20023822D0 (no) Luftfordeler
DE60203863D1 (de) X und Y wählbare Leitungseinheiten
FR2822657B1 (fr) Poignee de manutention